- Tips for Spending Holiday Time With Family Members Who Live with Dementia
- Tainted Cucumbers Now Linked to 100 Salmonella Cases in 23 States
- Check Your Pantry, Lay’s Classic Potato Chips Recalled Due to Milk Allergy Risk
- Norovirus Sickens Hundreds on Three Cruise Ships: CDC
- Not Just Blabber: What Baby’s First Vocalizations and Coos Can Tell Us
- What’s the Link Between Memory Problems and Sexism?
- Supreme Court to Decide on South Carolina’s Bid to Cut Funding for Planned Parenthood
- Antibiotics Do Not Increase Risks for Cognitive Decline, Dementia in Older Adults, New Data Says
- A New Way to Treat Sjögren’s Disease? Researchers Are Hopeful
- Some Abortion Pill Users Surprised By Pain, Study Says
Device Approved to Prevent Second Strokes in Certain Heart Patients
The Amplatzer PFO Occluder device has been approved by the U.S. Food and Drug Administration to prevent another stroke among people who had at least one prior stroke involving a PFO (patent foramen avale).
A PFO is a small hole in the heart that could allow passage of a blood clot.
Up to 30 percent of Americans have a cialis daily dosage PFO, the FDA explained in a news release. The condition typically causes no health issues and doesn’t require treatment.
However, in a small number of cases, the PFO provides “a path for a blood clot to travel to the brain where it [blocks] a blood vessel resulting in a stroke,” the agency added.
The new device is inserted via a catheter in a leg vein and is advanced to the heart.
It was FDA approved nearly a decade ago, but its manufacturer withdrew the application for approval after the agency told the manufacturer that more than 4,000 people could be eligible for the device, making the device ineligible for the agency’s humanitarian device exemption.
The new approval followed clinical testing of the device’s safety and effectiveness among more than 900 participants, aged 18 to 60 generic name of viagra years. Those who used the device plus blood-thinning medication were 50 percent less likely to have a new stroke, compared viagra and hemorrhoids with those who took blood-thinning medication alone, the FDA said.
Potential side effects of http://viagracanadianpharmacy-norx.com/ the device include heart injury, irregular heart rate or blood clot at the implant site. People http://genericcialis-onlineed.com/ with abnormal connections between the heart’s chambers or in whom unusual cardiovascular anatomy might inhibit the device’s implantation shouldn’t use the device, cialis professional online canada the FDA said.
The device is produced by St Jude Medical, based in Plymouth, Minn.
More information
To learn more, visit the FDA.
Source: HealthDay
Copyright © 2024 HealthDay. All rights reserved.